Swire is continually looking to expand into new areas of operation that complement its existing portfolio and provide opportunities for future growth. Its investment portfolio is currently focused on healthcare services. It is actively working to grow its healthcare services platform.
Swire has a controlling stake in DeltaHealth, a Chinese healthcare provider specialising in cardiovascular care. Deltahealth operates Shanghai DeltaHealth Hospital, a general hospital focusing on cardiovascular diseases, as well as DeltaWest Clinic, an outpatient clinic in the Gubei area of Changning district, to serve residents in Shanghai and the Yangtze River Delta.
Swire has an associate investment in Columbia China Healthcare, a business that owns and operates private hospitals and senior housing in the Yangtze River Delta area.
Swire has an associate investment in SHH Core Holding Limited, which owns Shenzhen New Frontier United Family Hospital, a private hospital operated by United Family Healthcare in Shenzhen and HEAL Medical Group. HEAL Medical Group operates three clinics in Hong Kong – HEAL Oncology, HEAL Medical and HEAL Fertility.
In July 2024, Swire made an investment in Indonesia Healthcare Corporation (IHC), a hospital group in Indonesia. IHC comprises 37 majority-owned hospitals and operates 73 clinics throughout Indonesia.
